Business Description
Bioporto AS
ISIN : DK0011048619
Description
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.51 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.07 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.44 | |||||
| Beneish M-Score | -1.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -7.6 | |||||
| 3-Year EBITDA Growth Rate | 17.7 | |||||
| 3-Year EPS without NRI Growth Rate | 18.4 | |||||
| 3-Year FCF Growth Rate | 3.8 | |||||
| 3-Year Book Growth Rate | -24.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.65 | |||||
| 9-Day RSI | 27.27 | |||||
| 14-Day RSI | 31.86 | |||||
| 6-1 Month Momentum % | 12.16 | |||||
| 12-1 Month Momentum % | -22.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.15 | |||||
| Quick Ratio | 4.91 | |||||
| Cash Ratio | 3.93 | |||||
| Days Inventory | 126.54 | |||||
| Days Sales Outstanding | 48.06 | |||||
| Days Payable | 176.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.1 | |||||
| Shareholder Yield % | -11.59 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.22 | |||||
| Operating Margin % | -189.54 | |||||
| Net Margin % | -175.62 | |||||
| FCF Margin % | -196.9 | |||||
| ROE % | -84.21 | |||||
| ROA % | -61.35 | |||||
| ROIC % | -219.38 | |||||
| ROC (Joel Greenblatt) % | -2769.62 | |||||
| ROCE % | -85.36 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 17.96 | |||||
| PB Ratio | 7.95 | |||||
| Price-to-Tangible-Book | 7.99 | |||||
| EV-to-EBIT | -9.39 | |||||
| EV-to-EBITDA | -9.75 | |||||
| EV-to-Forward-EBITDA | 5.74 | |||||
| EV-to-Revenue | 17.62 | |||||
| EV-to-Forward-Revenue | 11.92 | |||||
| EV-to-FCF | -9.06 | |||||
| Price-to-Median-PS-Value | 0.95 | |||||
| Price-to-Net-Current-Asset-Value | 8.88 | |||||
| Price-to-Net-Cash | 12.29 | |||||
| Earnings Yield (Greenblatt) % | -10.65 | |||||
| FCF Yield % | -10.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioporto AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 34.906 | ||
| EPS (TTM) (kr) | -0.16 | ||
| Beta | 1 | ||
| Volatility % | 71.73 | ||
| 14-Day RSI | 31.86 | ||
| 14-Day ATR (kr) | 0.080301 | ||
| 20-Day SMA (kr) | 1.7403 | ||
| 12-1 Month Momentum % | -22.19 | ||
| 52-Week Range (kr) | 1.21 - 3.85 | ||
| Shares Outstanding (Mil) | 429.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioporto AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioporto AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bioporto AS Frequently Asked Questions
What is Bioporto AS(OCSE:BIOPOR)'s stock price today?
The current price of OCSE:BIOPOR is kr1.60. The 52 week high of OCSE:BIOPOR is kr3.85 and 52 week low is kr1.21.
When is next earnings date of Bioporto AS(OCSE:BIOPOR)?
The next earnings date of Bioporto AS(OCSE:BIOPOR) is 2025-02-14 Est..
Does Bioporto AS(OCSE:BIOPOR) pay dividends? If so, how much?
Bioporto AS(OCSE:BIOPOR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers